John Hertia is President & VP at BIO-RAD LABORATORIES, INC. (BIO). They have made 6 open-market trades across 1 company since 2016, most recently 2019-09-12.
CIK 0000012208
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| BIO | 18,366 | $7.0M |
Shares reported on the most recent Form 4, priced at the 2019-09-13 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BIO | SELL | 2019-09-12 | 2019-09-13 | $328.25 | $262K | +3.0% | -0.4% | +8.9% |
| BIO | SELL | 2019-09-09 | 2019-09-10 | $336.47 | $149K | +6.8% | +0.3% | +10.6% |
| BIO | SELL | 2019-09-06 | 2019-09-09 | $336.50 | $1.7M | +1.7% | -3.2% | +7.1% |
| BIO | SELL | 2016-09-12 | 2016-09-13 | $155.02 | $113K | +2.8% | +2.6% | +14.3% |
| BIO | SELL | 2016-09-09 | 2016-09-13 | $157.81 | $539K | +2.8% | +2.6% | +14.3% |
| BIO | SELL | 2016-09-09 | 2016-09-13 | $158.57 | $426K | +2.8% | +2.6% | +14.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.